InterventionsHumans

SUN-344 Much Ado About Nothing: Tirzepatide and Medullary Thyroid Cancer Debunked

ENDO 2025 Abstract

The paper

Levy Barnett MJ, Lam JR, Casipit C et al.

ENDO 2025 Abstract · 22 Oct 2025 · CC BY-NC-ND

Presented at ENDO 2025

doi.org/10.1210/jendso/bvaf149.2358

Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Genetically proxied GIP pathway links to lower fracture risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026